Related references
Note: Only part of the references are listed.Heterogeneity in the responses of human lung mast cells to stem cell factor
A. Lewis et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2013)
PGE2 receptor (EP4) agonists: Potent dilators of human bronchi and future asthma therapy?
C. Benyahia et al.
PULMONARY PHARMACOLOGY & THERAPEUTICS (2012)
In vitro and in vivo characterization of PF-044189948, a novel, potent and selective prostaglandin EP2 receptor antagonist
K. J. af Forselles et al.
BRITISH JOURNAL OF PHARMACOLOGY (2011)
G-protein coupled receptors regulating cough
Sarah A. Maher et al.
CURRENT OPINION IN PHARMACOLOGY (2011)
Distinct PGE2-responder and non-responder phenotypes in human mast cell populations: All or nothing enhancement of antigen-dependent mediator release
Hye Sun Kuehn et al.
IMMUNOLOGY LETTERS (2011)
International Union of Basic and Clinical Pharmacology. LXXXIII: Classification of Prostanoid Receptors, Updating 15 Years of Progress
D. F. Woodward et al.
PHARMACOLOGICAL REVIEWS (2011)
EP4 receptor as a new target for bronchodilator therapy
James Buckley et al.
THORAX (2011)
Prostanoid receptor antagonists: development strategies and therapeutic applications
R. L. Jones et al.
BRITISH JOURNAL OF PHARMACOLOGY (2009)
Engagement of the EP2 prostanoid receptor closes the K+ channel KCa3.1 in human lung mast cells and attenuates their migration
S. Mark Duffy et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2008)
In vitro pharmacological characterization of CJ-042794, a novel, potent, and selective prostaglandin EP4 receptor antagonist
Akio Murase et al.
LIFE SCIENCES (2008)
Prostanoid receptor EP1 expression in breast cancer
Mangesh A. Thorat et al.
MODERN PATHOLOGY (2008)
Human mast cells express multiple EP receptors for prostaglandin E2 that differentially modulate activation responses
CL Feng et al.
BLOOD (2006)
Prostaglandin E2 activates EP2 receptors to inhibit human lung mast cell degranulation
LJ Kay et al.
BRITISH JOURNAL OF PHARMACOLOGY (2006)
Identification in human airways smooth muscle cells of the prostanoid receptor and signalling pathway through which PGE2 inhibits the release of GM-CSF
DL Clarke et al.
BRITISH JOURNAL OF PHARMACOLOGY (2004)
E-prostanoid (EP)2/EP4 receptor-dependent maturation of human monocyte-derived dendritic cells and induction of helper T2 polarization
S Kubo et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2004)
Functional pharmacology of human prostanoid EP2 and EP4 receptors
RJ Wilson et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2004)
The lung as a privileged site for the beneficial actions of PGE(2)
C Vancheri et al.
TRENDS IN IMMUNOLOGY (2004)
Characterization of novel stem cell factor responsive human mast cell lines LAD 1 and 2 established from a patient with mast cell sarcoma/leukemia;: activation following aggregation of FcεRI or FcγRI
AS Kirshenbaum et al.
LEUKEMIA RESEARCH (2003)
Role of cyclooxygenase-1 and-2, phospholipase C, and protein kinase C in prostaglandin-mediated gastroprotection
BM Peskar et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2003)
Mixed messages: modulation of inflammation and immune responses by prostaglandins and thromboxanes
SL Tilley et al.
JOURNAL OF CLINICAL INVESTIGATION (2001)
Genetic and pharmacological analysis of prostanoid receptor function
S Narumiya et al.
JOURNAL OF CLINICAL INVESTIGATION (2001)
Prostanoid receptors: Subtypes and signaling
RM Breyer et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY (2001)
Prostaglandin E2 decreases allergen-stimulated release of prostaglandin D2 in airways of subjects with asthma
TV Hartert et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2000)
The utilization of recombinant prostanoid receptors to determine the affinities and selectivities of prostaglandins and related analogs
M Abramovitz et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2000)
Share Paper
